What outrage? Ariad raises price of its leukemia drug four times so far this year
(By Ed Silverman for STAT) At a time when drug makers are under intense scrutiny for their pricing, Ariad Pharmaceuticals
Read More(By Ed Silverman for STAT) At a time when drug makers are under intense scrutiny for their pricing, Ariad Pharmaceuticals
Read More(‘By Ed Silverman for STAT) Mylan reached a $465 million settlement on Friday with the US Department of Justice and
Read More(By Meghana Keshavan for STAT) The race to create the next potent ovarian cancer drug is coming to a head. Ovarian
Read MoreThe outsourcing of Chronic Care Management to external technology-based firms is explored in an article posted www.healthcare-informatics.com by David Raths. Recapping the
Read More(By Emily Kopp for Kaiser Health News) As Zika skipped into Puerto Rico and then Florida this summer and threatened
Read MoreWhile it’s no secret that drug prices in the U.S. have been escalating at an alarming rate, one of the more
Read MoreFor individuals transitioning from exchange-purchased insurance plans to Medicare, there are number of key points that need to be taken
Read More(Source – CMS.gov) The Centers for Medicare & Medicaid Services (CMS) awarded a new contract to help support best health
Read MoreWhat may be considered positive signs for the future of Medicare’s Accountable Care Organization (ACO) experiment are presented in an
Read MoreIn an article posted on www.msn.com, Selena Maranjian of the Motley Fool takes a look at nine major statistics that will help
Read More